cytidine diphosphate choline has been researched along with Cerebral Infarction in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agulla, J; Argibay, B; Castillo, J; Pérez-Mato, M; Ramos-Cabrer, P | 1 |
| Hu, T; Huang, SQ; Huang, XX; Lu, RY; Peng, Y; Wang, YD; Yuan, F | 1 |
| Carceller, F; García, AG; López, MG; Roda, JM; Sobrado, M | 1 |
| Ataus, SA; Balkan, S; Locke, KW; Onal, MZ; Ozdem, SS | 1 |
| Cárdenas, A; Castillo, J; Dávalos, A; Fernández-Tomé, P; Hurtado, O; Leza, JC; Lizasoain, I; Lorenzo, P; Lozano, R; Moro, MA; Sánchez, V; Secades, JJ | 1 |
| Brickman, AM; Browndyke, J; Cohen, RA; Gordon, N; Gunstad, J; Haque, O; Moser, DJ; Ott, BR; Paul, RH | 1 |
| Sun, LJ; Sun, YQ; Yan, YZ; Zhong, SQ; Zhong, YY | 1 |
| Meng, D; Shi, F; Zhou, J | 1 |
| Katayama, Y; Terashi, A | 1 |
| Fisher, M; Locke, KW; Sandage, BW; Schäbitz, WR; Takano, K; Weber, J | 1 |
| Aronowski, J; Grotta, JC; Strong, R | 1 |
| Fisher, M; Li, F; Locke, KW; Onal, MZ; Sandage, BW; Tatlisumak, T | 1 |
| Fisher, M; Irie, K; Li, F; Locke, KW; Sandage, BW; Schäbitz, WR | 1 |
| Andersen, M; Boysen, G; Choi, SC; Meden, P; Overgaard, K | 1 |
| Li, Q; Shuaib, A; Yang, Y | 1 |
| Fujishima, M; Kameyama, M; Kutsuzawa, T; Omae, T; Otomo, E; Sakai, F; Sakuma, A; Tazaki, Y | 1 |
5 trial(s) available for cytidine diphosphate choline and Cerebral Infarction
| Article | Year |
|---|---|
Human tissue kallikrein promoted activation of the ipsilesional sensorimotor cortex after acute cerebral infarction.
Topics: Acupuncture Therapy; Cerebellum; Cerebral Cortex; Cerebral Infarction; Cytidine Diphosphate Choline; Humans; Magnetic Resonance Imaging; Nootropic Agents; Recovery of Function; Tissue Kallikreins | 2011 |
Progressive morphometric and cognitive changes in vascular dementia.
Topics: Aged; Aged, 80 and over; Anthropometry; Brain; Cerebral Infarction; Cytidine Diphosphate Choline; Dementia, Vascular; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Nootropic Agents; Severity of Illness Index | 2005 |
Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction.
Topics: Acute Disease; Adult; Aged; Aspirin; Blood Viscosity; Capsules; Cerebral Infarction; Cytidine Diphosphate Choline; Diuretics, Osmotic; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hematocrit; Hemorheology; Humans; Male; Mannitol; Middle Aged; Nootropic Agents; Piracetam; Platelet Aggregation Inhibitors | 2005 |
[Curative effect of soybean lecithin on cerebral infarction].
Topics: Cerebral Infarction; Cytidine Diphosphate Choline; Female; Glycine max; Humans; Lecithins; Male; Middle Aged; Phytotherapy | 2001 |
Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cerebral Infarction; Choline; Clinical Trials as Topic; Consciousness; Cytidine Diphosphate Choline; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Random Allocation | 1988 |
11 other study(ies) available for cytidine diphosphate choline and Cerebral Infarction
| Article | Year |
|---|---|
Serial MRI study of the enhanced therapeutic effects of liposome-encapsulated citicoline in cerebral ischemia.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Injections, Intravenous; Liposomes; Magnetic Resonance Imaging; Male; Nootropic Agents; Rats; Rats, Sprague-Dawley; Stroke | 2011 |
Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia.
Topics: Animals; Apoptosis; Brain Ischemia; Calcium Channel Blockers; Cerebral Cortex; Cerebral Infarction; Cytidine Diphosphate Choline; Drug Therapy, Combination; In Situ Nick-End Labeling; Male; Nerve Degeneration; Neurons; Nimodipine; Nootropic Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Treatment Outcome; Up-Regulation | 2003 |
The effects of citicoline and lamotrigine alone and in combination following permanent middle cerebral artery occlusion in rats.
Topics: Analysis of Variance; Animals; Anticonvulsants; Brain; Brain Ischemia; Cerebral Infarction; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Lamotrigine; Male; Neurologic Examination; Random Allocation; Rats; Rats, Wistar; Statistics, Nonparametric; Tetrazolium Salts; Treatment Outcome; Triazines | 2004 |
Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Topics: Adenosine Triphosphate; Amino Acid Transport System X-AG; Animals; Animals, Newborn; Astrocytes; Biological Transport; Brain; Brain Ischemia; Cell Survival; Cells, Cultured; Cerebral Infarction; Coculture Techniques; Cytidine Diphosphate Choline; Cytoprotection; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; L-Lactate Dehydrogenase; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Rats; Rats, Inbred F344; Rats, Wistar; Symporters | 2005 |
[Agents for the improvement of brain metabolism].
Topics: Cerebral Infarction; Cytidine Diphosphate Choline; Humans | 1982 |
The effects of prolonged treatment with citicoline in temporary experimental focal ischemia.
Topics: Animals; Arterial Occlusive Diseases; Brain Diseases; Cerebral Arteries; Cerebral Infarction; Cytidine Diphosphate Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; Ischemic Attack, Transient; Male; Nootropic Agents; Rats; Rats, Sprague-Dawley; Survival Rate; Treatment Outcome | 1996 |
Citicoline for treatment of experimental focal ischemia: histologic and behavioral outcome.
Topics: Animals; Arterial Occlusive Diseases; Atrophy; Behavior, Animal; Brain Ischemia; Cerebral Infarction; Cytidine Diphosphate Choline; Male; Neuroprotective Agents; Nootropic Agents; Rats; Rats, Inbred SHR; Reperfusion Injury | 1996 |
Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats.
Topics: Animals; Cerebral Infarction; Cytidine Diphosphate Choline; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Antagonists; Ischemic Attack, Transient; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Survival Analysis | 1997 |
Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia.
Topics: Animals; Cerebral Infarction; Cytidine Diphosphate Choline; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Fibroblast Growth Factor 2; Follow-Up Studies; Infusions, Intravenous; Ischemic Attack, Transient; Male; Nootropic Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Treatment Outcome | 1999 |
Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model.
Topics: Animals; Carotid Artery Thrombosis; Cerebral Angiography; Cerebral Infarction; Cytidine Diphosphate Choline; Drug Therapy, Combination; Fibrinolytic Agents; Infusions, Intravenous; Injections, Intraperitoneal; Male; Nootropic Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 1999 |
Evaluating the efficacy of citicoline in embolic ischemic stroke in rats: neuroprotective effects when used alone or in combination with urokinase.
Topics: Animals; Cerebral Infarction; Cytidine Diphosphate Choline; Drug Therapy, Combination; Intracranial Embolism; Ischemic Attack, Transient; Male; Motor Activity; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Urokinase-Type Plasminogen Activator | 2000 |